UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Safety pharmacology of acute psilocybin administration in healthy participants
These findings suggest that a single administration of psilocybin is safe with regard to acute psychological and physical harm in healthy participants in a controlled research setting.
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies
We conducted a systematic review and a dose-response meta-analysis to find the optimal dosage of psilocybin.
Dose-response relationships of LSD-induced subjective experiences in humans
Most scales revealed a sigmoid-like increase of effects, with a plateauing at around 100 μg.
Body mass index (BMI) does not predict responses to psilocybin
These findings have important implications for the standardization of a fixed therapeutic dose in psychedelic-assisted therapy.
Dose-response relationships of LSD-induced subjective experiences in humans
Here we present the first meta-analysis establishing dose-response relationship estimates of the phenomenological states induced by LSD.
Effects of naturalistic psychedelic use on depression, anxiety, and well-being: Associations with patterns of use, reported harms, and transformative mental states
the current study add to a growing database indicating that psychedelic use may provide a wide range of mental health benefits
Safety pharmacology of acute LSD administration in healthy subjects
LSD dosage effects on both positive and negative experiences.